NT-18 * PHASE I CLINICAL TRIAL OF ONCOLYTIC VIRUS...

Neuro-Oncology 2014 / 11 Vol. 16; Iss. suppl 5

NT-18 * PHASE I CLINICAL TRIAL OF ONCOLYTIC VIRUS DELTA-24-RGD (DNX-2401) WITH BIOLOGICAL ENDPOINTS: IMPLICATIONS FOR VIRO-IMMUNOTHERAPY

Lang, F. F., Conrad, C., Gomez-Manzano, C., Tufaro, F., Sawaya, R., Weinberg, J., Prabhu, S., Fuller, G., Aldape, K., Fueyo, J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
16
Language:
english
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/nou265.17
Date:
November, 2014
File:
PDF, 28 KB
english, 2014
Conversion to is in progress
Conversion to is failed